Summary
The clinical manifestations of platelet dense () granule defects are easy bruising as well as epistaxis and bleeding after delivery, tooth extractions and surgical procedures.
The observed symptoms may be explained either by a decreased number of granules or by a defect in the uptake/release of granule contents. We have developed a method to study platelet dense granule storage and release. The uptake of the fluorescent marker, mepacrine, into the platelet dense granule was measured using flow cytometry. The platelet population was identified by the size and binding of a phycoerythrin-conjugated antibody against GPIb. Cells within the discrimination frame were analysed for green (mepacrine) fluorescence. Both resting platelets and platelets previously stimulated with collagen and the thrombin receptor agonist peptide SFLLRN was analysed for mepacrine uptake. By subtracting the value for mepacrine uptake after stimulation from the value for uptake without stimulation for each individual, the platelet dense granule release capacity could be estimated.
Whole blood samples from 22 healthy individuals were analysed. Mepacrine incubation without previous stimulation gave mean fluorescence intensity (MFI) values of 836 (mean  1 SD, range 69-91). The difference in MFI between resting and stimulated platelets was 287 (range 17-40). Six members of a family of whom one had a known -storage pool disease were analysed. The two members (mother and son) who had prolonged bleeding times also had MFI-values disparate from the normal population in this analysis. The values of one daughter with mild bleeding problems but a normal bleeding time were in the lower part of the reference interval.
Introduction
Defects in platelet granules ("storage pool deficiencies") have been reported both for dense granules () and  granules, separately and combined 1 . The observed symptoms may be explained either by the absence or decreased number of granules or by a defect in the uptake/release of granule contents 2 . Acquired storage pool disorders were also found, often associated with in vivo platelet activation 3 . -storage pool deficiency may occur as a single abnormality or as part of inherited disorders such as the HermanskyPudlak, Chediak-Higashi and Wiskott-Aldrich syndromes 1 . The clinical manifestations are easy bruising as well as epistaxis and bleeding after delivery, tooth extractions and surgical procedures 2 . Severe haemorrhage is rare except after ingestion of anti-platelet drugs such as aspirin. The inheritance of the defect is unclear, although it is possible that several different genetic alterations causes the same defect 1 .
Platelets in patients with -storage pool disease contain less adenine nucleotides than normal platelets, and the serotonin content varies. Morphological examination shows that the platelets look rather normal except for the decrease or absence of dense bodies 1 .
Routine methods give variable results among patients with -storage pool deficiency, and even in the same patient at different points of time. The bleeding time is usually prolonged, but this as well as the aggregation of platelets may be normal 1 . Thirty-five percent of a patient group with prolonged bleeding time but normal aggregation patterns and normal von Willebrand factor levels were shown to have a decreased release of ATP and decreased numbers of dense granules 4 .
To study the number of dense granules visually in individual platelets is an alternative to the studies of release from dense granules. The dense character of the granules make them visible in transmission electron microscopy without any staining 4 . Uranaffin or osmium staining might, however, accentuate the abnormalities 1 . Mepacrine (also called quinacrine) is a fluorescent acridine derivative which binds with high affinity to adenine nucleotides and is rapidly and selectively taken up by platelet dense granules 2, 5, 6 . In other cells such as monocytes, mepacrine accumulates in lysosomes, but in platelets only the dense bodies are stained 7 . Mepacrine-treated platelets from patients with dense granule abnormalities have earlier been investigated with fluorescent microscopy to determine the number of dense granules 8, 9 . The development of the flow cytometer opened a new possibility of studying platelet dense granules with mepacrine in a simple and rapid way. This has been described both using whole blood 10 and platelet rich plasma (PRP) 2 . Both studies have reported reduced staining of platelets from patients with -storage pool disease compared with the staining of platelets from normal controls. In both articles the diagnosis is based on mepacrine uptake by unstimulated platelets, although the thrombin-induced release of mepacrine from platelets of a patient with Hermansky-Pudlak syndrome was reported to be reduced when compared with normals 10 . Our objective was to modify the method to include both dense granule uptake and release, which would make it possible to identify both patients with defects in the number of dense granules and patients with defects in the release from dense granule. This is important since both of these abnormalities may lead to the symptoms characteristic for -storage pool disease.
Materials and methods

Reagents and antibodies
Hanks balanced salt solution without Ca 
Patients and controls
22 healthy volunteers without bleeding tendency were examined (14 males, 8 females, ages 22-60). All participants were informed about the aims of the study and accepted participation. No medication with a potential of interfering with platelet function was allowed for 10 days before blood sampling.
The six patients were from a family in which several members showed symptoms of impaired platelet function. We examined the mother, age 48, her son, age 8, her twin daughters, age 9, and a daughter, age 25. The elder daughter was married to her cousin, age 32, who was included as he was also reported to have problems. The son and the mother had serious bleeding problems, one of the twin daughters showed mild symptoms and the other had no symptoms. The elder daughter had experienced a cerebral haemorrhage. When investigated in Malmö 1993, the eight years old son and another son, age 19, were diagnosed with storage pool disease as they showed reduced platelet adhesiveness and an absence of a secondary aggregation wave in response to 6 ADP.
Blood collection
Venous blood was collected in 5 mL vacuum tubes (Vacutainer system, Becton
Dickinson, Rutherford, NJ) containing 0.5 ml 0.129 mol/L sodium citrate.
Mepacrine labelling
The labelling was performed 1.5 hours after blood sampling. Before the start of the labelling procedure, the blood samples were gently mixed for at least 10 minutes. Sixty To check if aggregation occurred during the stimulation, 1 g/mL of the platelet inhibitor MK-852 was added to the 1:40 dilution 10 minutes before the start of the mepacrine labelling procedure described above. A sample without MK-852 was prepared and run in parallel. This was repeated three times.
Flow cytometry
The analyses were performed with a Cytoron Absolute flow cytometer (Ortho, Raritan, NJ, USA). The light scattering properties and red fluorescence from the anti-GPIbphycoerythrin antibody identified the platelet cluster, and a discrimination frame was placed around it. All particles inside the frame were analysed for green (mepacrine) fluorescence. A gate was set to divide the platelets in the mepacrine unmarked samples so that 97-98% of the platelets were "negative" (i.e. "gated in region 1") and 1 By comparing the staining of stimulated and unstimulated platelets we were able to identify one patient (the mother, patient 1 in fig. 1 and 2 ), who had normal staining without stimulation but who did not release a normal amount of granule contents upon stimulation. This patient would have been classified as normal in analyses performed as previously described 2, 10 , since defects in the release reaction were not detected there.
Compared with electron microscopy, the flow cytometric method is much less timeconsuming, the sample preparation is easier and the counting of cells is more rapid.
Furthermore, the special equipment and competence required for electron microscopy are not available everywhere. The rapid counting is also an advantage as compared with fluorescent microscopy of mepacrine treated platelets. One thousand cells in each duplicate sample were counted here, as compared with studies with fluorescent microscopy, where only about 50 cells per individual were examined 8, 9 .
The diagnosis of dense granule defects by aggregometry 1 has not been successful in all cases 4 , since some patients manifested normal aggregation patterns. The advantages detected with this flow cytometric method suggest that it should be a good complement to the platelet function tests performed in laboratories world-wide as a fast, simple and reliable assay for dense granule function. Table 2 . MFI values for six members of a family with suspected -storage pool disease.
The reference intervals given are mean values for the healthy individuals  2 SD. 
